In this guide
Tesamorelin vs MOTS-c at a glance
Different targets, different evidence
Tesamorelin and MOTS-c both come up when people look for help with a leaner body, but they act in different places. Tesamorelin signals the pituitary gland to release growth hormone, while MOTS-c is a small peptide encoded in your mitochondrial DNA that's being studied for how muscle uses glucose.
The bigger gap in any tesamorelin vs MOTS c comparison is evidence. Tesamorelin's large human trials were in adults with HIV-associated lipodystrophy, plus one smaller trial in obesity. MOTS-c research is mostly in mice and cells.
Tesamorelin for visceral fat evidence, MOTS-c for metabolic research
Neither one is approved for weight loss, so the right fit depends on your goals and a clinician's review.
- Tesamorelin lowered visceral fat 15.2% in a 26‑week HIV trial
- MOTS‑c prevented diet‑induced obesity in mice in a 2015 study
- The Tesamorelin pen holds 30 mg, the MOTS‑c pen holds 40 mg
- Both pens are $224 for the first month on subscription
30mg
of tesamorelin in each Tesamorelin pen
MOTS-c pen: 40 mg
The stronger human data belongs to tesamorelin, but for one approved medical use. MOTS-c has early animal data and very little human testing so far.
| Feature | Tesamorelin | MOTS-c |
|---|---|---|
| What it is | A synthetic analog of GHRH, a hormone made in the brain | A 16‑amino‑acid peptide encoded in mitochondrial DNA |
| How it works | Prompts the pituitary to release growth hormone | Studied for AMPK activation and glucose use in muscle |
| Main research focus | Visceral (deep belly) fat | Insulin sensitivity and diet‑induced weight gain |
| Evidence stage | Two large 26‑week trials in adults with HIV lipodystrophy, one smaller trial in obesity | Mostly mouse and cell studies |
| FDA status | Brand Egrifta is approved only to reduce excess abdominal fat in HIV‑infected adults with lipodystrophy | Not FDA‑approved for any use |
| In the Peppi pen | 30 mg of tesamorelin | 40 mg of MOTS‑c |
| Peppi price | $224 first month on subscription, then $359 | $224 first month on subscription, then $359 |
Peppi's pens are prescription peptides, not FDA-approved products, and every batch is tested by independent labs for potency, sterility, pH and endotoxins. If you end up using MOTS c and tesamorelin side by side, each pen has its own lot number, and you can look up Peppi's batch test results for either one.
How tesamorelin targets visceral fat
Human trials, one narrow group
Tesamorelin works upstream. It's a synthetic analog of growth hormone-releasing factor, the signal that tells the pituitary to release growth hormone, a hormone that builds tissue and breaks down fat.
The case for tesamorelin for visceral fat comes from people with HIV who built up deep belly fat during antiretroviral therapy. In a 2007 New England Journal of Medicine trial, 412 patients took tesamorelin or a placebo daily for 26 weeks. Visceral fat fell 15.2% on tesamorelin and rose 5.0% on placebo.
Those trials are why the brand version, Egrifta, is FDA-approved for one use: reducing excess abdominal fat in HIV-infected adults with lipodystrophy. They didn't include people without HIV, so the numbers aren't a forecast for your own waistline. A smaller 2012 trial in adults with abdominal obesity, 60 people without HIV and with low growth hormone output, found less visceral fat after 12 months of tesamorelin than on placebo.
Tesamorelin weight loss is also a bit of a misnomer. The Egrifta WR prescribing information says the drug isn't indicated for weight loss management because it has a weight-neutral effect. In the trials, body weight barely moved while trunk fat went down and lean body mass went up by about 1.2 to 1.3 kg.
Peppi's Tesamorelin pen holds 30 mg of tesamorelin and is designed to support visceral fat reduction, lean body composition and metabolic health.

Featured pen
Tesamorelin
30 mg of tesamorelin in a pre-filled, twist-to-dose pen, prescribed only after a licensed clinician reviews your intake.
$449 $224 first month 50% off
Daniel M., a verified buyer, described his experience this way: “I had been doing the right things but still wasn’t seeing much change around my waist. My friend recommended Tesamorelin from Peppi and I noticed my clothes started fitting better and I could actually see the progress. Having a clinician check in made it feel a lot more legit than things I’d tried before.”
How MOTS-c peptide supports metabolism
A signal from your mitochondria
MOTS-c is a 16-amino-acid peptide encoded in your mitochondrial DNA, and researchers think it acts as a metabolic signal, mainly in skeletal muscle. A team led by University of Southern California scientists described it in 2015.
The MOTS c peptide is coded by a short stretch of the mitochondrial 12S rRNA gene. In the 2015 Cell Metabolism study that named it, its main target appeared to be skeletal muscle, where it led to activation of AMPK, an enzyme that senses cellular energy.
The MOTS c benefits people read about come from mouse work like this:
- Middle-aged mice: 7 days of MOTS-c restored muscle insulin sensitivity to the level of young mice
- Mice on a high-fat diet: MOTS-c prevented diet-induced obesity while calorie intake stayed the same
- Energy use: treated mice burned more energy, including more heat production
- Liver: fat buildup in the liver was sharply reduced in high-fat-fed mice
Human research is much thinner. The human studies cited in a 2019 paper from the same USC group measured natural MOTS-c levels in blood rather than giving people the peptide, and those levels tracked with markers like BMI and fasting insulin in some groups. Peppi describes MOTS-c as being studied for its potential role in metabolism, cellular energy, endurance and insulin sensitivity, and the MOTS-c peptide pen holds 40 mg.

Featured pen
MOTS-c
40 mg of MOTS-c in a pre-filled pen, dispensed by a named U.S. pharmacy after a licensed clinician approves your prescription.
$449 $224 first month 50% off
Kevin L., a verified buyer, shared this: “I was just dragging through the afternoons at work a bit. Adding MOTS-C gave me very steady clean energy and an extra dose of motivation. I’m finally pushing past plateaus and feel like I have way more energy.”
MOTS-c for weight loss & insulin sensitivity
Promising mice, open questions
MOTS c for weight loss is a mouse story so far. In the 2015 study, high-fat-fed mice given MOTS-c avoided the weight gain seen in untreated mice while eating the same calories, which points to higher energy use rather than a smaller appetite.
Insulin is the other half of the picture. A 2019 mitochondrial peptide insulin study in Physiological Reports gave obese male mice on a high-fat diet MOTS-c injections twice a day for three days. By the end, their blood glucose was significantly lower than in mice given water, insulin only trended lower, and three groups of blood metabolites that run high in obese and type 2 diabetic models fell.
That's why MOTS-c turns up on lists of peptides for insulin resistance. The authors called it an exercise mimetic, but these results come from mice, and human trials are needed before anyone can say it works the same way in people.
On blood sugar, tesamorelin points the other way. Its prescribing information warns that glucose intolerance or diabetes may develop and advises checking glucose before and during therapy. The 2007 trial alone found no significant differences in glycemic measures, but across the label's trials, 5% of tesamorelin patients reached an HbA1c of 6.5% or higher by week 26, compared with 1% on placebo.
Tesamorelin dosage vs MOTS-c dosage
Set by your clinician, not a chart
There's no tesamorelin dosage or MOTS c dosage to copy here. A licensed clinician personalizes your dose after reviewing your intake, and the two pens differ mainly in what's inside them.
Published tesamorelin doses come from brand formulations used in adults with HIV, so they aren't a guide for a Peppi plan. MOTS-c has no established human dose, since nearly all of its research is in animals and cells.
- Tesamorelin pen: 30 mg of tesamorelin
- MOTS-c pen: 40 mg of MOTS-c
- Both: a twist-to-dose selector, with no mixing or measuring from vials
- Both: one pen is a one-month supply, refilled every 28 days
- Both: unlimited video calls and messaging with your care team
Peppi's note on timing applies to either pen. Peptide therapy is cumulative, and Peppi recommends committing 4-6 months for results to build.
Taking tesamorelin & MOTS-c together
Two pathways, one care plan
Using both is a clinical call, not a default. We found no published study that tested tesamorelin and MOTS-c together, so any plan that pairs them rests on their separate research.
Tesamorelin may fit if
- Deep belly fat is your main concern
- You want the peptide with human trial data
- You care more about body composition than the scale
MOTS-c may fit if
- Energy, endurance and metabolic health are your goals
- You're interested in insulin sensitivity research
- You're comfortable with mostly animal evidence
The appeal of pairing them is that they act on different systems, one through growth hormone and one through energy signaling in muscle. That's also why a clinician should review the pairing. Tesamorelin's label notes that it raises IGF-1 and can affect blood sugar, and it lists fluid retention, joint pain and injection site reactions among possible side effects.
People searching for peptides for fat loss often land on both, even though they take very different routes. Peppi's peptide goal quiz is a quick way to match your goals to a pen before a licensed clinician reviews your intake.
Not sure if tesamorelin or MOTS-c fits your goals?
Take the quizQuestions about tesamorelin & MOTS-c
Frequently asked questions
Short answers on belly fat, stacking and how fast MOTS-c works.
Is MOTS-c or Tesamorelin Better for Belly Fat?
The stronger evidence for deep belly fat belongs to tesamorelin. In a 26-week trial of 412 adults with HIV, visceral fat fell 15.2% on tesamorelin and rose 5.0% on placebo. Outside HIV, a smaller 12-month trial in 60 adults with abdominal obesity also found less visceral fat than on placebo. MOTS-c prevented fat gain in mice on a high-fat diet, but human data is very limited. A clinician can weigh both against your health history.
Can You Stack Tesamorelin & MOTS-c?
That's a decision for your clinician. We found no published study that tested the two together, so a stack rests on each peptide's separate research. Because tesamorelin can raise IGF-1 and affect blood sugar, it's worth a review before adding anything else. At Peppi, each peptide comes in its own pen, and a licensed clinician reviews your intake before anything ships.
How Fast Does MOTS-c Work?
There's no human answer yet. In mice, changes showed up within days. After three days of injections, obese mice had significantly lower blood glucose than untreated mice, and seven days restored muscle insulin sensitivity in middle-aged mice. Mouse timelines don't carry over to people. Peppi's guidance is that peptide therapy is cumulative, and it recommends 4-6 months for results to build.
*These statements have not been evaluated by the Food and Drug Administration. Peppi peptides are dispensed only with a prescription.




